par cyril | Jan 10, 2024 | Application Notes
Drugs targeting RNA-protein interactions are part of the next generation of medicines, but the lack of predictive and cost-effective cell-based high-throughput screening assays has been a significant barrier to their development. Synsight’s automated MTBench® platform...
par cyril | Déc 13, 2023 | Application Notes
Drug R&D productivity declines The introduction of a new drug to the market is currently associated with a lengthy timeline of approximately 10-15 years, requiring from $1 to $3 billion. Throughout the drug development journey, a therapeutic agent faces a...
